Osteoporosis costing NSW and ACT: A burden of disease analysis - 2012 to 2022

Burden of Disease Reports This report outlines osteoporosis prevalence and cost in NSW and AC

Cost of living with Parkinson\u27s disease over 12 months in Australia: a prospective cohort study

Background. Parkinson disease (PD) is a costly chronic condition in terms of managing both motor and nonmotor symptoms. The burden of disease is high for individuals, caregivers, and the health system. The aim of this study is to estimate the annual cost of PD from the household, health system, and societal perspectives. Methods. A prospective cohort study of newly referred people with PD to a specialist PD clinic in Melbourne, Australia. Participants completed baseline and monthly health resource use questionnaires and Medicare data were collected over 12 months. Results. 87 patients completed the 12-month follow-up assessments. The mean annual cost per person to the health care system was $32,556 AUD. The burden to society was an additional$45,000 per annum per person with PD. The largest component of health system costs were for hospitalisation (69% of total costs). The costs for people with moderate to severe disease were almost 4 times those with mild PD ($63,569 versus$17,537 p < 0.001 ). Conclusion. PD is associated with significant costs to individuals and to society. Costs escalated with disease severity suggesting that the burden to society is likely to grow with the increasing disease prevalence that is associated with population ageing

Trial protocol: a clustered, randomised, longitudinal, type 2 translational trial of alcohol consumption and alcohol-related harm among adolescents in Australia

This cluster randomised control trial is designed to evaluate whether the Communities That Care intervention (CTC) is effective in reducing the proportion of secondary school age adolescents who use alcohol before the Australian legal purchasing age of 18\ua0years. Secondary outcomes are other substance use and antisocial behaviours. Long term economic benefits of reduced alcohol use by adolescents for the community will also be assessed.Fourteen communities and 14 other non-contiguous communities will be matched on socioeconomic status (SES), location, and size. One of each pair will be randomly allocated to the intervention in three Australian states (Victoria, Queensland and Western Australia). A longitudinal survey will recruit grade 8 and 10 students (M\ua0= 15\ua0years old, N\ua0= 3500) in 2017 and conduct follow-up surveys in 2019 and 2021 (M\ua0= 19\ua0years old). Municipal youth populations will also be monitored for trends in alcohol-harms using hospital and police administrative data.Community-led interventions that systematically and strategically implement evidence-based programs have been shown to be effective in producing population-level behaviour change, including reduced alcohol and drug use. We expect that the study will be associated with significant effects on alcohol use amongst adolescents because interventions adopted within communities will be based on evidence-based practices and target specific problems identified from surveys conducted within each community.The trial was retrospectively registered in September, 2017 ( ACTRN12616001276448 ), as communities were selected prior to trial registration; however, participants were recruited after registration. Findings will be disseminated in peer-review journals and community fora

Osteoporosis costing Northern Territory: A burden of disease analysis - 2012 to 2022

Burden of Disease Reports This report outlines osteoporosis prevalence and cost in the Northern Territor

Osteoporosis costing Tasmania: A burden of disease analysis - 2012 to 2022

Burden of Disease Reports This report outlines osteoporosis prevalence and cost in Tasmani

Osteoporosis costing Victoria: A burden of disease analysis - 2012 to 2022

Burden of Disease Reports This report outlines osteoporosis prevalence and cost in Victori